pmc-enju-pas Home  

PMC:1064895 / 20649-21991 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T15909 0-2 TO denotes To
T15910 3-14 VB denotes investigate
T15911 15-22 RB denotes further
T15912 23-26 DT denotes the
T15913 27-40 JJ denotes intracellular
T15914 41-50 NN denotes signaling
T15915 51-58 NN denotes pathway
T15916 59-68 VB denotes activated
T15917 69-71 IN denotes by
T15918 72-80 JJ denotes anti-CD3
T15919 81-85 CC denotes plus
T15920 86-95 NN denotes anti-CD28
T15921 95-96 -COMMA- denotes ,
T15922 97-109 NN denotes concanavalin
T15923 110-111 NN denotes A
T15924 111-112 -COMMA- denotes ,
T15925 113-116 NN denotes PHA
T15926 117-120 CC denotes and
T15927 121-126 NN denotes IL-15
T15928 126-127 -COMMA- denotes ,
T15929 128-131 CC denotes and
T15930 132-143 JJ denotes responsible
T15931 144-147 IN denotes for
T15932 148-156 VB denotes inducing
T15933 157-162 NN denotes IL-17
T15934 163-173 NN denotes expression
T15935 173-174 -COMMA- denotes ,
T15936 175-177 PRP denotes we
T15937 178-187 VB denotes performed
T15938 188-190 DT denotes an
T15939 191-206 JJ denotes electrophoretic
T15940 207-221 NN denotes mobility-shift
T15941 222-227 NN denotes assay
T15942 228-229 -LRB- denotes (
T15943 229-233 NN denotes EMSA
T15944 233-234 -RRB- denotes )
T15945 235-237 IN denotes of
T15946 238-243 NN denotes NF-κB
T15947 244-255 NN denotes recognition
T15948 256-261 NN denotes sites
T15949 262-264 IN denotes in
T15950 265-268 DT denotes the
T15951 269-278 NN denotes promoters
T15952 279-281 IN denotes of
T15953 282-287 NN denotes IL-17
T15954 289-291 IN denotes As
T15955 292-297 VB denotes shown
T15956 298-300 IN denotes in
T15957 301-305 NNP denotes Fig.
T15958 306-308 NNP denotes 7a
T15959 308-309 -COMMA- denotes ,
T15960 310-317 JJ denotes nuclear
T15961 318-326 NN denotes extracts
T15962 327-331 IN denotes from
T15963 332-334 NN denotes RA
T15964 335-339 NN denotes PBMC
T15965 340-350 VB denotes stimulated
T15966 351-355 IN denotes with
T15967 356-364 JJ denotes anti-CD3
T15968 365-369 CC denotes plus
T15969 370-379 NN denotes anti-CD28
T15970 380-381 -LRB- denotes (
T15971 381-385 NN denotes lane
T15972 386-387 CD denotes 2
T15973 387-388 -RRB- denotes )
T15974 389-401 VB denotes demonstrated
T15975 402-411 VB denotes increased
T15976 412-419 NN denotes binding
T15977 420-422 IN denotes of
T15978 423-428 NN denotes NF-κB
T15979 429-431 TO denotes to
T15980 432-437 NN denotes IL-17
T15981 438-447 NN denotes promoters
T15982 448-450 IN denotes in
T15983 451-461 NN denotes comparison
T15984 462-466 IN denotes with
T15985 467-471 DT denotes that
T15986 472-474 IN denotes of
T15987 475-483 NN denotes controls
T15988 484-485 -LRB- denotes (
T15989 485-489 NN denotes lane
T15990 490-491 CD denotes 1
T15991 491-492 -RRB- denotes )
T15992 494-495 DT denotes A
T15993 496-506 NN denotes supershift
T15994 507-512 NN denotes assay
T15995 513-525 VB denotes demonstrated
T15996 526-533 VB denotes shifted
T15997 534-539 NN denotes bands
T15998 540-542 IN denotes in
T15999 543-546 NN denotes p65
T16000 547-550 CC denotes and
T16001 551-554 NN denotes p50
T16002 555-556 -LRB- denotes (
T16003 556-561 NN denotes lanes
T16004 562-563 CD denotes 3
T16005 564-567 CC denotes and
T16006 568-569 CD denotes 4
T16007 569-570 -RRB- denotes )
T16008 571-574 RB denotes not
T16009 575-577 IN denotes in
T16010 578-583 NN denotes c-Rel
T16011 584-585 -LRB- denotes (
T16012 585-589 NN denotes lane
T16013 590-591 CD denotes 5
T16014 591-592 -RRB- denotes )
T16015 594-596 IN denotes In
T16016 597-603 JJ denotes normal
T16017 604-608 NN denotes PBMC
T16018 609-612 DT denotes the
T16019 613-617 JJ denotes same
T16020 618-625 NN denotes pattern
T16021 626-629 VB denotes was
T16022 630-638 VB denotes observed
T16023 638-639 -COMMA- denotes ,
T16024 640-643 CC denotes but
T16025 644-647 DT denotes the
T16026 648-654 NN denotes degree
T16027 655-657 IN denotes of
T16028 658-663 NN denotes NF-κB
T16029 664-674 NN denotes activation
T16030 675-677 IN denotes by
T16031 678-686 NN denotes anti-CD3
T16032 687-691 CC denotes plus
T16033 692-701 NN denotes anti-CD28
T16034 702-705 VB denotes was
T16035 706-710 RB denotes less
T16036 711-718 JJ denotes intense
T16037 719-723 IN denotes than
T16038 724-728 DT denotes that
T16039 729-731 IN denotes in
T16040 732-734 NN denotes RA
T16041 735-739 NN denotes PBMC
T16042 740-741 -LRB- denotes (
T16043 741-745 NN denotes Fig.
T16044 746-748 NN denotes 7b
T16045 748-749 -RRB- denotes )
T16046 751-753 TO denotes To
T16047 754-761 VB denotes confirm
T16048 762-765 DT denotes the
T16049 766-770 NN denotes link
T16050 771-778 IN denotes between
T16051 779-783 NN denotes PI3K
T16052 784-792 NN denotes activity
T16053 793-796 CC denotes and
T16054 797-802 NN denotes NF-κB
T16055 802-803 -COMMA- denotes ,
T16056 804-806 PRP denotes we
T16057 807-816 VB denotes performed
T16058 817-821 NN denotes EMSA
T16059 822-824 TO denotes to
T16060 825-834 VB denotes determine
T16061 835-838 DT denotes the
T16062 839-844 NN denotes NF-κB
T16063 845-852 NN denotes binding
T16064 853-861 NN denotes activity
T16065 862-867 IN denotes after
T16066 868-877 NN denotes treatment
T16067 878-882 IN denotes with
T16068 883-887 CC denotes both
T16069 888-896 NN denotes LY294002
T16070 897-900 CC denotes and
T16071 901-905 NN denotes PDTC
T16072 907-911 DT denotes Both
T16073 912-918 NN denotes agents
T16074 919-924 VB denotes block
T16075 925-930 NN denotes NF-κB
T16076 931-942 JJ denotes DNA-binding
T16077 943-951 NN denotes activity
T16078 952-954 IN denotes in
T16079 955-958 DT denotes the
T16080 959-964 NN denotes IL-17
T16081 965-973 NN denotes promoter
T16082 974-975 -LRB- denotes (
T16083 975-979 NN denotes Fig.
T16084 980-982 NN denotes 7c
T16085 982-983 -RRB- denotes )
T16086 985-992 NN denotes Western
T16087 993-1001 NN denotes blotting
T16088 1002-1005 IN denotes for
T16089 1006-1011 NN denotes IκB-α
T16090 1012-1018 VB denotes showed
T16091 1019-1029 NN denotes inhibition
T16092 1030-1032 IN denotes of
T16093 1033-1044 NN denotes degradation
T16094 1045-1047 IN denotes of
T16095 1048-1053 NN denotes IκB-α
T16096 1054-1056 IN denotes by
T16097 1057-1065 NN denotes LY294002
T16098 1066-1069 CC denotes and
T16099 1070-1074 NN denotes PDTC
T16100 1075-1077 IN denotes at
T16101 1078-1081 DT denotes the
T16102 1082-1086 JJ denotes same
T16103 1087-1091 NN denotes time
T16104 1092-1093 -LRB- denotes (
T16105 1093-1097 NN denotes Fig.
T16106 1098-1100 NN denotes 7c
T16107 1100-1101 -RRB- denotes )
T16108 1103-1105 IN denotes In
T16109 1106-1114 NN denotes contrast
T16110 1114-1115 -COMMA- denotes ,
T16111 1116-1119 DT denotes the
T16112 1120-1124 NN denotes AP-1
T16113 1125-1132 NN denotes pathway
T16114 1133-1136 VB denotes was
T16115 1137-1140 RB denotes not
T16116 1141-1150 VB denotes activated
T16117 1151-1153 IN denotes by
T16118 1154-1165 NN denotes stimulation
T16119 1166-1170 IN denotes with
T16120 1171-1179 JJ denotes anti-CD3
T16121 1180-1184 CC denotes plus
T16122 1185-1194 JJ denotes anti-CD28
T16123 1195-1196 -LRB- denotes (
T16124 1196-1200 NN denotes data
T16125 1201-1204 RB denotes not
T16126 1205-1210 VB denotes shown
T16127 1210-1211 -RRB- denotes )
T16128 1211-1212 -COMMA- denotes ,
T16129 1213-1226 VB denotes demonstrating
T16130 1227-1231 IN denotes that
T16131 1232-1237 NN denotes NF-κB
T16132 1238-1240 VB denotes is
T16133 1241-1244 DT denotes the
T16134 1245-1249 JJ denotes main
T16135 1250-1263 JJ denotes intracellular
T16136 1264-1273 NN denotes signaling
T16137 1274-1281 NN denotes pathway
T16138 1282-1284 IN denotes in
T16139 1285-1290 NN denotes IL-17
T16140 1291-1301 NN denotes production
T16141 1302-1304 IN denotes by
T16142 1305-1314 VB denotes activated
T16143 1315-1319 NN denotes PBMC
T16144 1320-1324 IN denotes from
T16145 1325-1333 NN denotes patients
T16146 1334-1338 IN denotes with
T16147 1339-1341 NN denotes RA
R8599 T15910 T15909 arg1Of investigate,To
R8600 T15910 T15911 arg1Of investigate,further
R8601 T15915 T15910 arg2Of pathway,investigate
R8602 T15915 T15912 arg1Of pathway,the
R8603 T15915 T15913 arg1Of pathway,intracellular
R8604 T15915 T15914 arg1Of pathway,signaling
R8605 T15915 T15916 arg2Of pathway,activated
R8606 T15915 T15930 arg1Of pathway,responsible
R8607 T15916 T15929 arg1Of activated,and
R8608 T15918 T15919 arg1Of anti-CD3,plus
R8609 T15919 T15921 arg1Of plus,","
R8610 T15920 T15919 arg2Of anti-CD28,plus
R8611 T15921 T15924 arg1Of ",",","
R8612 T15923 T15921 arg2Of A,","
R8613 T15923 T15922 arg1Of A,concanavalin
R8614 T15924 T15926 arg1Of ",",and
R8615 T15925 T15924 arg2Of PHA,","
R8616 T15926 T15916 arg1Of and,activated
R8617 T15926 T15917 arg2Of and,by
R8618 T15927 T15926 arg2Of IL-15,and
R8619 T15929 T15928 arg1Of and,","
R8620 T15930 T15929 arg2Of responsible,and
R8621 T15930 T15931 arg1Of responsible,for
R8622 T15932 T15931 arg2Of inducing,for
R8623 T15934 T15932 arg2Of expression,inducing
R8624 T15934 T15933 arg1Of expression,IL-17
R8625 T15936 T15937 arg1Of we,performed
R8626 T15937 T15909 modOf performed,To
R8627 T15937 T15935 arg1Of performed,","
R8628 T15941 T15937 arg2Of assay,performed
R8629 T15941 T15938 arg1Of assay,an
R8630 T15941 T15939 arg1Of assay,electrophoretic
R8631 T15941 T15940 arg1Of assay,mobility-shift
R8632 T15941 T15942 arg1Of assay,(
R8633 T15941 T15945 arg1Of assay,of
R8634 T15943 T15942 arg2Of EMSA,(
R8635 T15944 T15942 arg3Of ),(
R8636 T15948 T15945 arg2Of sites,of
R8637 T15948 T15946 arg1Of sites,NF-κB
R8638 T15948 T15947 arg1Of sites,recognition
R8639 T15948 T15949 arg1Of sites,in
R8640 T15951 T15949 arg2Of promoters,in
R8641 T15951 T15950 arg1Of promoters,the
R8642 T15951 T15952 arg1Of promoters,of
R8643 T15953 T15952 arg2Of IL-17,of
R8644 T15955 T15954 arg2Of shown,As
R8645 T15955 T15956 arg1Of shown,in
R8646 T15958 T15956 arg2Of 7a,in
R8647 T15958 T15957 arg1Of 7a,Fig.
R8648 T15961 T15960 arg1Of extracts,nuclear
R8649 T15961 T15962 arg1Of extracts,from
R8650 T15961 T15974 arg1Of extracts,demonstrated
R8651 T15964 T15962 arg2Of PBMC,from
R8652 T15964 T15963 arg1Of PBMC,RA
R8653 T15964 T15965 arg2Of PBMC,stimulated
R8654 T15965 T15966 arg1Of stimulated,with
R8655 T15967 T15968 arg1Of anti-CD3,plus
R8656 T15968 T15966 arg2Of plus,with
R8657 T15968 T15970 arg1Of plus,(
R8658 T15969 T15968 arg2Of anti-CD28,plus
R8659 T15971 T15970 arg2Of lane,(
R8660 T15971 T15972 arg1Of lane,2
R8661 T15973 T15970 arg3Of ),(
R8662 T15974 T15954 arg1Of demonstrated,As
R8663 T15974 T15959 arg1Of demonstrated,","
R8664 T15974 T15982 arg1Of demonstrated,in
R8665 T15976 T15974 arg2Of binding,demonstrated
R8666 T15976 T15975 arg2Of binding,increased
R8667 T15976 T15977 arg1Of binding,of
R8668 T15976 T15979 arg1Of binding,to
R8669 T15978 T15977 arg2Of NF-κB,of
R8670 T15981 T15979 arg2Of promoters,to
R8671 T15981 T15980 arg1Of promoters,IL-17
R8672 T15983 T15982 arg2Of comparison,in
R8673 T15983 T15984 arg1Of comparison,with
R8674 T15985 T15984 arg2Of that,with
R8675 T15985 T15986 arg1Of that,of
R8676 T15987 T15986 arg2Of controls,of
R8677 T15987 T15988 arg1Of controls,(
R8678 T15989 T15988 arg2Of lane,(
R8679 T15989 T15990 arg1Of lane,1
R8680 T15991 T15988 arg3Of ),(
R8681 T15994 T15992 arg1Of assay,A
R8682 T15994 T15993 arg1Of assay,supershift
R8683 T15994 T15995 arg1Of assay,demonstrated
R8684 T15995 T16009 arg1Of demonstrated,in
R8685 T15997 T15995 arg2Of bands,demonstrated
R8686 T15997 T15996 arg2Of bands,shifted
R8687 T15997 T15998 arg1Of bands,in
R8688 T15999 T16000 arg1Of p65,and
R8689 T16000 T15998 arg2Of and,in
R8690 T16000 T16002 arg1Of and,(
R8691 T16001 T16000 arg2Of p50,and
R8692 T16004 T16005 arg1Of 3,and
R8693 T16005 T16002 arg2Of and,(
R8694 T16005 T16003 arg1Of and,lanes
R8695 T16006 T16005 arg2Of 4,and
R8696 T16007 T16002 arg3Of ),(
R8697 T16009 T16008 arg1Of in,not
R8698 T16010 T16009 arg2Of c-Rel,in
R8699 T16010 T16011 arg1Of c-Rel,(
R8700 T16012 T16011 arg2Of lane,(
R8701 T16012 T16013 arg1Of lane,5
R8702 T16014 T16011 arg3Of ),(
R8703 T16017 T16015 arg2Of PBMC,In
R8704 T16017 T16016 arg1Of PBMC,normal
R8705 T16020 T16018 arg1Of pattern,the
R8706 T16020 T16019 arg1Of pattern,same
R8707 T16020 T16021 arg1Of pattern,was
R8708 T16020 T16022 arg2Of pattern,observed
R8709 T16022 T16015 arg1Of observed,In
R8710 T16022 T16021 arg2Of observed,was
R8711 T16022 T16024 arg1Of observed,but
R8712 T16024 T16023 arg1Of but,","
R8713 T16026 T16025 arg1Of degree,the
R8714 T16026 T16027 arg1Of degree,of
R8715 T16026 T16030 arg1Of degree,by
R8716 T16026 T16034 arg1Of degree,was
R8717 T16026 T16036 arg1Of degree,intense
R8718 T16029 T16027 arg2Of activation,of
R8719 T16029 T16028 arg1Of activation,NF-κB
R8720 T16031 T16032 arg1Of anti-CD3,plus
R8721 T16032 T16030 arg2Of plus,by
R8722 T16033 T16032 arg2Of anti-CD28,plus
R8723 T16034 T16024 arg2Of was,but
R8724 T16036 T16034 arg2Of intense,was
R8725 T16036 T16035 arg1Of intense,less
R8726 T16036 T16037 arg1Of intense,than
R8727 T16038 T16037 arg2Of that,than
R8728 T16038 T16039 arg1Of that,in
R8729 T16041 T16039 arg2Of PBMC,in
R8730 T16041 T16040 arg1Of PBMC,RA
R8731 T16041 T16042 arg1Of PBMC,(
R8732 T16044 T16042 arg2Of 7b,(
R8733 T16044 T16043 arg1Of 7b,Fig.
R8734 T16045 T16042 arg3Of ),(
R8735 T16047 T16046 arg1Of confirm,To
R8736 T16049 T16047 arg2Of link,confirm
R8737 T16049 T16048 arg1Of link,the
R8738 T16049 T16050 arg1Of link,between
R8739 T16052 T16051 arg1Of activity,PI3K
R8740 T16052 T16053 arg1Of activity,and
R8741 T16053 T16050 arg2Of and,between
R8742 T16054 T16053 arg2Of NF-κB,and
R8743 T16056 T16047 arg1Of we,confirm
R8744 T16056 T16057 arg1Of we,performed
R8745 T16057 T16046 modOf performed,To
R8746 T16057 T16055 arg1Of performed,","
R8747 T16058 T16057 arg2Of EMSA,performed
R8748 T16058 T16059 modOf EMSA,to
R8749 T16060 T16059 arg1Of determine,to
R8750 T16060 T16065 arg1Of determine,after
R8751 T16064 T16060 arg2Of activity,determine
R8752 T16064 T16061 arg1Of activity,the
R8753 T16064 T16062 arg1Of activity,NF-κB
R8754 T16064 T16063 arg1Of activity,binding
R8755 T16066 T16065 arg2Of treatment,after
R8756 T16066 T16067 arg1Of treatment,with
R8757 T16069 T16070 arg1Of LY294002,and
R8758 T16070 T16067 arg2Of and,with
R8759 T16070 T16068 arg1Of and,both
R8760 T16071 T16070 arg2Of PDTC,and
R8761 T16073 T16072 arg1Of agents,Both
R8762 T16073 T16074 arg1Of agents,block
R8763 T16077 T16074 arg2Of activity,block
R8764 T16077 T16075 arg1Of activity,NF-κB
R8765 T16077 T16076 arg1Of activity,DNA-binding
R8766 T16077 T16078 arg1Of activity,in
R8767 T16081 T16078 arg2Of promoter,in
R8768 T16081 T16079 arg1Of promoter,the
R8769 T16081 T16080 arg1Of promoter,IL-17
R8770 T16081 T16082 arg1Of promoter,(
R8771 T16084 T16082 arg2Of 7c,(
R8772 T16084 T16083 arg1Of 7c,Fig.
R8773 T16085 T16082 arg3Of ),(
R8774 T16087 T16086 arg1Of blotting,Western
R8775 T16087 T16088 arg1Of blotting,for
R8776 T16087 T16090 arg1Of blotting,showed
R8777 T16089 T16088 arg2Of IκB-α,for
R8778 T16091 T16090 arg2Of inhibition,showed
R8779 T16091 T16092 arg1Of inhibition,of
R8780 T16093 T16092 arg2Of degradation,of
R8781 T16093 T16094 arg1Of degradation,of
R8782 T16093 T16096 arg1Of degradation,by
R8783 T16093 T16100 arg1Of degradation,at
R8784 T16095 T16094 arg2Of IκB-α,of
R8785 T16097 T16098 arg1Of LY294002,and
R8786 T16098 T16096 arg2Of and,by
R8787 T16099 T16098 arg2Of PDTC,and
R8788 T16103 T16100 arg2Of time,at
R8789 T16103 T16101 arg1Of time,the
R8790 T16103 T16102 arg1Of time,same
R8791 T16103 T16104 arg1Of time,(
R8792 T16106 T16104 arg2Of 7c,(
R8793 T16106 T16105 arg1Of 7c,Fig.
R8794 T16107 T16104 arg3Of ),(
R8795 T16109 T16108 arg2Of contrast,In
R8796 T16113 T16111 arg1Of pathway,the
R8797 T16113 T16112 arg1Of pathway,AP-1
R8798 T16113 T16114 arg1Of pathway,was
R8799 T16113 T16116 arg2Of pathway,activated
R8800 T16116 T16108 arg1Of activated,In
R8801 T16116 T16110 arg1Of activated,","
R8802 T16116 T16114 arg2Of activated,was
R8803 T16116 T16115 arg1Of activated,not
R8804 T16116 T16128 arg1Of activated,","
R8805 T16116 T16129 modOf activated,demonstrating
R8806 T16118 T16116 arg1Of stimulation,activated
R8807 T16118 T16117 arg2Of stimulation,by
R8808 T16118 T16119 arg1Of stimulation,with
R8809 T16120 T16121 arg1Of anti-CD3,plus
R8810 T16122 T16121 arg2Of anti-CD28,plus
R8811 T16124 T16119 arg2Of data,with
R8812 T16124 T16120 arg1Of data,anti-CD3
R8813 T16124 T16122 arg1Of data,anti-CD28
R8814 T16124 T16123 arg2Of data,(
R8815 T16124 T16126 arg2Of data,shown
R8816 T16126 T16125 arg1Of shown,not
R8817 T16127 T16123 arg3Of ),(
R8818 T16131 T16132 arg1Of NF-κB,is
R8819 T16132 T16129 arg2Of is,demonstrating
R8820 T16132 T16130 arg1Of is,that
R8821 T16137 T16132 arg2Of pathway,is
R8822 T16137 T16133 arg1Of pathway,the
R8823 T16137 T16134 arg1Of pathway,main
R8824 T16137 T16135 arg1Of pathway,intracellular
R8825 T16137 T16136 arg1Of pathway,signaling
R8826 T16137 T16138 arg1Of pathway,in
R8827 T16137 T16141 arg1Of pathway,by
R8828 T16140 T16138 arg2Of production,in
R8829 T16140 T16139 arg1Of production,IL-17
R8830 T16143 T16141 arg2Of PBMC,by
R8831 T16143 T16142 arg2Of PBMC,activated
R8832 T16143 T16144 arg1Of PBMC,from
R8833 T16145 T16144 arg2Of patients,from
R8834 T16145 T16146 arg1Of patients,with
R8835 T16147 T16146 arg2Of RA,with